||||||||||PanCytoVir (probenecid) / TrippBio Trial completion: A Study to Evaluate the Efficacy of PanCytoVir (clinicaltrials.gov) - Oct 13, 2022 P2, N=75, Completed, Sponsor: TrippBio, Inc. Not yet recruiting --> Completed
||||||||||PanCytoVir (probenecid) / TrippBio New P2 trial: A Study to Evaluate the Efficacy of PanCytoVir (clinicaltrials.gov) - Jul 4, 2022 P2, N=75, Not yet recruiting, Sponsor: TrippBio, Inc.